NCT06719739

Brief Summary

We have designed this prospective study to evaluate macular involvement and epiretinal membrane (ERM) grading by OCT in eyes with ERM and to compare clinical outcomes after implantation of Enhance IOL with standard monofocal IOL in eyes with ERM grading preoperatively, aiming to find out whether functional IOL is benefit for patients with ERM.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Sep 2024Sep 2026

Study Start

First participant enrolled

September 21, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 4, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 6, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 21, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 21, 2026

Last Updated

April 8, 2026

Status Verified

December 1, 2025

Enrollment Period

2 years

First QC Date

December 4, 2024

Last Update Submit

April 2, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • UDVA

    Uncorrected distance visual acuity

    1-day/1-week/1-month/3-months/6-monhts/1-year/2-years

Study Arms (2)

Functional IOL

EXPERIMENTAL

Experimental group

Device: Intraocular lens implantation

Monofocal IOL

OTHER

Control Group

Device: Intraocular lens implantation

Interventions

Cataract patients scheduled for surgery will be evaluated by OCT, and those diagnosed with macular epiretinal membrane will be implanted in different IOLs according to the patients' decision: monodical IOL or functional IOL.

Functional IOLMonofocal IOL

Eligibility Criteria

Age20 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Requirement for cataract extraction
  • Age \> 40 years
  • Axial length in 21mm to 25mm
  • ERM

You may not qualify if:

  • Residual corneal astigmatism \> 1.0 D
  • Amblyopia
  • Previous ocular surgery
  • Other ocular pathologies apart from mERM, such as diabetic retinopathy, macular degeneration, glaucoma with field defects
  • Requirements for further ocular surgery (other than Nd:YAG capsulotomy) or retinal laser treatments during the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Eye and Ear, Nose, and Throat Hospital of Fudan University

Shanghai, Shanghai Municipality, 200031, China

RECRUITING

Shanghai Heping Eye Hospital

Shanghai, Shanghai Municipality, 200081, China

RECRUITING

MeSH Terms

Conditions

CataractEpiretinal Membrane

Interventions

Lens Implantation, Intraocular

Condition Hierarchy (Ancestors)

Lens DiseasesEye DiseasesRetinal Diseases

Intervention Hierarchy (Ancestors)

Refractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, Operative

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 4, 2024

First Posted

December 6, 2024

Study Start

September 21, 2024

Primary Completion (Estimated)

September 21, 2026

Study Completion (Estimated)

September 21, 2026

Last Updated

April 8, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations